Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-24

Clinical Trial Update: Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder [Phase 4]

View source ↗

Summary

Post-marketing Phase 4 study evaluating Predictix antidepressant clinician software support tool for prescribing antidepressants in major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Taliaz Ltd. | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN